Global Medical REIT (NYSE:XRN) CEO Mark Okey Decker, Jr. Acquires 6,875 Shares of Stock

Global Medical REIT Inc. (NYSE:XRN) CEO Mark Okey Decker, Jr. bought 6,875 shares of the stock in a transaction dated Tuesday, August 11th. The shares were acquired at an average price of $35.92 per share, for a total transaction of $246,950.00. Following the completion of the purchase, the chief executive officer directly owned 75,199 shares in the company, valued at approximately $2,701,148.08. This trade represents a 10.06% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink.

Global Medical REIT Stock Performance

XRN traded up $0.25 during trading on Thursday, hitting $36.52. 100,235 shares of the company traded hands, compared to its average volume of 89,274. The firm has a market cap of $483.50 million, a P/E ratio of 9.82 and a beta of 1.09. The stock’s fifty day moving average is $36.59 and its 200 day moving average is $35.80. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 1.68. Global Medical REIT Inc. has a one year low of $29.05 and a one year high of $39.93.

Global Medical REIT (NYSE:XRN) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $4.78 EPS for the quarter, topping the consensus estimate of $0.83 by $3.95. The business had revenue of $39.75 million for the quarter. Global Medical REIT had a net margin of 36.82% and a return on equity of 13.74%. As a group, equities analysts predict that Global Medical REIT Inc. will post 3.06 EPS for the current fiscal year.

Institutional Investors Weigh In On Global Medical REIT

Hedge funds have recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd boosted its holdings in shares of Global Medical REIT by 1,001.4% in the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 793 shares of the company’s stock worth $27,000 after purchasing an additional 721 shares in the last quarter. Fifth Third Bancorp raised its holdings in shares of Global Medical REIT by 35.3% during the 4th quarter. Fifth Third Bancorp now owns 1,417 shares of the company’s stock valued at $48,000 after buying an additional 370 shares in the last quarter. Virtus Advisers LLC lifted its position in Global Medical REIT by 46.5% in the 4th quarter. Virtus Advisers LLC now owns 2,418 shares of the company’s stock worth $82,000 after buying an additional 768 shares during the last quarter. Eurizon Capital SGR S.p.A. purchased a new stake in Global Medical REIT in the fourth quarter worth approximately $92,000. Finally, SG Americas Securities LLC purchased a new stake in Global Medical REIT in the fourth quarter worth approximately $121,000. Institutional investors own 57.52% of the company’s stock.

Trending Headlines about Global Medical REIT

Here are the key news stories impacting Global Medical REIT this week:

• Positive Sentiment: Director Charles Fitzgerald purchased 14,000 shares for approximately $500,920 at an average price of $35.78, increasing his direct ownership by 11.21%. This followed his purchase of another 27,600 shares, worth about $991,944, on August 10. SEC insider purchase filing
• Positive Sentiment: CEO Mark Okey Decker Jr. bought 8,000 shares for $287,040 on August 10 and an additional 550 shares for $19,800 on August 11. The purchases increased his holdings by 13.38% and 0.81%, respectively, signaling management confidence in the company’s valuation and outlook. CEO insider buying report
• Positive Sentiment: Global Medical REIT reported quarterly earnings per share of $4.78, exceeding the $0.83 consensus estimate by $3.95, with revenue of $39.75 million. The company posted a 36.82% net margin and 13.74% return on equity, while analysts expect full-year EPS of $3.06.
• Positive Sentiment: Some analysts remain constructive: Citizens JMP raised its price target to $42 from $40 and maintained an outperform rating. The average analyst price target is $40.25, above the recent trading level.
• Neutral Sentiment: Institutional ownership remains substantial at 57.52%. Invesco increased its position, and several other investment firms recently initiated or expanded holdings, providing some support from professional investors.
• Negative Sentiment: Analyst sentiment is mixed, with an overall “Hold” rating. Compass Point cut its price target to $38 from $50, Wall Street Zen downgraded the stock to “Sell,” and Raymond James initiated coverage at “Market Perform.”
• Negative Sentiment: The REIT carries meaningful leverage, with a debt-to-equity ratio of 1.68 and current and quick ratios of 0.68, factors that could limit financial flexibility if interest rates or property-market conditions worsen.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on the company. Compass Point reissued a “neutral” rating and issued a $38.00 price objective (down from $50.00) on shares of Global Medical REIT in a report on Thursday, May 7th. BMO Capital Markets upped their price objective on shares of Global Medical REIT from $39.00 to $40.00 and gave the company a “market perform” rating in a report on Monday, July 13th. Citizens Jmp increased their target price on shares of Global Medical REIT from $40.00 to $42.00 and gave the stock a “market outperform” rating in a research report on Tuesday, May 26th. Weiss Ratings downgraded shares of Global Medical REIT from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Thursday, July 30th. Finally, Wall Street Zen lowered shares of Global Medical REIT from a “hold” rating to a “sell” rating in a research report on Saturday, May 9th. Two research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $40.25.

Global Medical REIT Company Profile

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.